Other
Accounts Payable
Vertex Pharmaceuticals Accounts Payable decreased by 7.0% to $35.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.9%, from $26.20M to $35.60M. Over 4 years (FY 2021 to FY 2025), Accounts Payable shows an upward trend with a 3.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase represents a source of cash flow by delaying payments, while a decrease indicates the company is paying down its obligations faster.
Detailed definition
The net change in the amount the company owes to suppliers for goods and services purchased on credit. This represents a...
Peer comparison
Analyzed through Days Payable Outstanding (DPO) to understand payment terms relative to industry standards.
Metric ID:
other_increase_decrease_in_accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.70M | $2.30M | $53.90M | -$14.50M | $45.30M | -$69.90M | $159.90M | $12.18M | $12.18M | $12.18M | $12.18M | $100.00K | -$25.10M | $66.10M | $8.40M | $26.20M | $7.60M | -$35.30M | $38.30M | $35.60M |
| QoQ Change | — | +116.8% | >999% | -126.9% | +412.4% | -254.3% | +328.8% | -92.4% | +0.0% | +0.0% | +0.0% | -99.2% | <-999% | +363.3% | -87.3% | +211.9% | -71.0% | -564.5% | +208.5% | -7.0% |
| YoY Change | — | — | — | — | +430.7% | <-999% | +196.7% | +184.0% | -73.1% | +117.4% | -92.4% | -99.2% | -306.2% | +442.9% | -31.0% | >999% | +130.3% | -153.4% | +356.0% | +35.9% |
Range-$69.90M – $159.90M
CAGR+22.3%
Avg YoY Growth>999%
Median YoY Growth+76.6%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's accounts payable?
- Vertex Pharmaceuticals (VRTX) reported accounts payable of $35.60M in Q1 2026.
- How has Vertex Pharmaceuticals's accounts payable changed year-over-year?
- Vertex Pharmaceuticals's accounts payable increased by 35.9% year-over-year, from $26.20M to $35.60M.
- What is the long-term trend for Vertex Pharmaceuticals's accounts payable?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's accounts payable has grown at a 3.6% compound annual growth rate (CAGR), from $31.90M to $36.80M.
- What does accounts payable mean?
- The change in money the company owes to its suppliers.